大禹生物
(871970)
| 流通市值：3.61亿 | | | 总市值：5.79亿 |
| 流通股本：6944.59万 | | | 总股本：1.11亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 19,849,530.87 | 22,757,512.26 | 21,137,550.78 | 19,800,900.3 |
| 应收票据及应收账款 | 23,720,209.87 | 24,167,802.85 | 23,523,865.57 | 26,561,244.19 |
| 应收账款 | 23,720,209.87 | 24,167,802.85 | 23,523,865.57 | 26,561,244.19 |
| 预付款项 | 2,175,563.39 | 1,761,129.39 | 2,503,322.44 | 2,232,952.47 |
| 其他应收款合计 | 55,292.2 | 16,573.05 | 4,632.5 | 2,453.5 |
| 存货 | 22,978,526.59 | 26,794,482.01 | 32,740,754.23 | 30,789,663.07 |
| 其他流动资产 | 740,737.62 | 892,843.09 | 1,111,389.47 | 1,026,571.21 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 69,519,860.54 | 76,390,342.65 | 81,021,514.99 | 80,413,784.74 |
| 非流动资产: | | | | |
| 固定资产 | 290,700,115.04 | 296,702,261.28 | 303,377,951.92 | 159,187,288.72 |
| 在建工程 | - | 359,867.69 | - | 140,939,470.79 |
| 无形资产 | 23,890,941.3 | 23,923,354.62 | 24,153,787.74 | 24,384,220.86 |
| 长期待摊费用 | - | 6,272.62 | 15,682.03 | 25,091.44 |
| 递延所得税资产 | 624,731.44 | 624,731.44 | 624,731.44 | 624,731.44 |
| 其他非流动资产 | 16,702,854.88 | 16,819,359.73 | 16,838,954.88 | 18,138,154.88 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 331,918,642.66 | 338,435,847.38 | 345,011,108.01 | 343,298,958.13 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 401,438,503.2 | 414,826,190.03 | 426,032,623 | 423,712,742.87 |
| 流动负债: | | | | |
| 短期借款 | 56,700,000 | 66,000,000 | 68,500,000 | 62,055,238.9 |
| 应付票据及应付账款 | 8,426,884.56 | 8,414,868.03 | 10,134,503.37 | 9,172,605.46 |
| 应付账款 | 8,426,884.56 | 8,414,868.03 | 10,134,503.37 | 9,172,605.46 |
| 合同负债 | 3,403,787.68 | 1,788,751.47 | 1,674,782.44 | 748,640.33 |
| 应付职工薪酬 | 7,118,390.8 | 6,764,113.58 | 6,739,200.49 | 7,622,194.7 |
| 应交税费 | 581,800.55 | 189,968.2 | 278,191.82 | 213,065.88 |
| 其他应付款合计 | 313,520 | 253,606.5 | 435,214 | 328,325 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 76,544,383.59 | 83,411,307.78 | 87,761,892.12 | 80,140,070.27 |
| 非流动负债: | | | | |
| 递延收益 | 23,702,915.65 | 24,556,665.67 | 25,410,415.69 | 26,264,165.71 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 23,702,915.65 | 24,556,665.67 | 25,410,415.69 | 26,264,165.71 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 100,247,299.24 | 107,967,973.45 | 113,172,307.81 | 106,404,235.98 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 111,360,400 | 111,360,400 | 111,360,400 | 111,360,400 |
| 资本公积 | 85,593,738.02 | 85,593,738.02 | 85,593,738.02 | 85,593,738.02 |
| 减:库存股 | 5,109,738.08 | 5,109,738.08 | 5,109,738.08 | 5,109,738.08 |
| 盈余公积 | 16,853,068.95 | 16,853,068.95 | 16,853,068.95 | 16,853,068.95 |
| 未分配利润 | 92,493,735.07 | 98,160,747.69 | 104,162,846.3 | 108,611,038 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 301,191,203.96 | 306,858,216.58 | 312,860,315.19 | 317,308,506.89 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 301,191,203.96 | 306,858,216.58 | 312,860,315.19 | 317,308,506.89 |
| 负债和股东权益合计 | 401,438,503.2 | 414,826,190.03 | 426,032,623 | 423,712,742.87 |
| 公告日期 | 2024-10-28 | 2024-08-28 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |